A single atom cobalt anchored MXene bifunctional platform for rapid, label-free and high-throughput biomarker analysis and tissue imaging

Few of single-atom materials have been served as platform to analyze small molecules for surface assisted laser desorption/ionization mass spectrometry (SALDI-MS). Herein, a novel single Co atom-anchored MXene (Co-N-Ti3C2) is prepared to achieve enhanced SALDI-MS and mass spectrometry imaging (MSI) performance for the first time. The Co-N-Ti3C2 films were prepared by a simple in situ self-assembly strategy to generate an efficient SALDI-MS platform. Compared to typical inorganic/organic matrices, Co-N-Ti3C2 films exhibit superior performance in small molecules detection with ultra-high sensitivity (LOD at amol level), excellent repeatability (CV <4%), clean background and wide analyte coverage, enabling accurate quantitative analysis of various low-concentration metabolites from 1 μL biofluid in seconds. Its usage efficiently enhanced SALDI-MS detection of various small-molecule biomarkers such as amino acids, succinic acid, itaconic acid, arachidonic acid, citrulline, prostaglandin E2, creatinine, uric acid, glutamine, D-mannose, cholesterol and inositol in positive ion mode. The blood glucose level in humans was successfully determined from a linearity concentration range (0.25-10 mM). Notably, the Co-N-Ti3C2 assisted SALDI-MSI enables study the spatial distribution of small molecules covering the range central to metabolomics at a high resolution on a tissue section. Furthermore, Co-N-Ti3C2 platform revealed a specific peak profile that distinguishes osteoarthritis (OA) from rheumatoid arthritis (RA) tissue. Density functional theory theoretical investigation revealed that single Co atoms anchored on Ti3C2 could highly enhanced the ionization ability of metabolites, resulting in high-sensitivity and heterogeneous metabolome coverage.

Large-scale in situ self-assembly and doping engineering of zinc ferrite nanoclusters for high performance bioimaging

Iron oxide nanomaterials has good biocompatibility and safety, and has been used as contrast agents for magnetic resonance imaging (MRI). However, its clinical usefulness is hampered by its difficult preparation on large scale, its rapid clearance in vivo and low target tissue enrichment efficiency. Here, we report the synthesis of water-soluble, biocompatible, superparamagnetic non-stoichiometric zinc ferrite nanoclusters (nZFNCs) of approximately 50 g in a single batch using a one-pot synthesis technique. nZFNCs is a secondary cluster structure with a size of about 40 nm composed of zinc-doped iron oxide nanoparticles with a size of about 6 nm. The surface of nZFNCS is endowed with a large number of carboxyl groups as active sites. By simply controlling the synthesis process and adjusting the proportion of metal precursors, the amount of zinc doping can be controlled, while maintaining the same size to ensure similar pharmacokinetics. Compared with undoped, the magnetic responsiveness and relaxation efficiency of nZFNCs are significantly improved, and the transverse relaxation efficiency (r2) can reach 425.5 mM-1 s-1 (doping amount x = 0.25), which is 7 times higher than that of commercial Resovist and 10 times higher than that of Feridex. In vivo imaging results also further confirmed the excellent contrast enhancement performance of the nanoclusters, which can achieve high contrast for more than 2 h in the liver. The advantage of this platform over comparable systems is that the contrast enhancement features are derived from simple techniques that do not require complex physical and chemical methods.

In situ self-assembled macroporous interconnected nanosheet arrays of Ni-1,3,5-benzenetricarboxylate metal - organic framework on Ti mesh as high-performance oxygen evolution electrodes

Highly efficient metal-organic framework (MOF)-based oxygen evolution reaction (OER) catalysts are desirable for water splitting, but their development remains challenging due to poor accessibility of coordinatively unsaturated metal (cum) sites and low intrinsic activity. A large-area three-dimensional (3-D) macroporous interconnected nanosheet array of Ni-1,3,5-benzenetricarboxylate has been in situ self-assembled on Ti mesh (TM) by using ethanol as the solvent and high-affinity oxide layer on TM to promote in situ nucleation. The obtained nanoarchitecture exhibits much superior catalytic activity compared to most reported catalysts including MOF-based catalysts, other precious-metal-free ones, and Ir/Ru-based ones. Additionally, this electrode undergoes no current decay after 300 cyclic voltammetry (CV) cycles and can maintain at 250 mA cm^-2 for over 266 h. The excellent catalytic performance is mainly due to the 3-D macroporous and interconnected nanosheet array structure improving cum site exposure and charge transport and in situ activated cum cations enhancing OH^- adsorption. This work not only develops a facile and economical approach to synthesize 3-D macroporous interconnected MOF nanosheet arrays to simultaneously increase the number, exposure, and intrinsic activity of active sites and facilitate charge transport for high-performance eletrocatalysis, but provides scientific insights into the mechanisms for self-assembly of this unique nanoarchitecture and for the high OER performance.

Flowerlike BiOCl nanospheres fabricated by an in situ self-assembly strategy for efficiently enhancing photocatalysis

For semiconductor-based photocatalytic reactions, defect engineering has been proven as an efficient approach to enhance the photocatalytic performance. In this work, a synergistically PVP/EG-assisted in situ self-assembly strategy has been successfully developed for preparing flowerlike BiOCl nanospheres (NSP) assembled by ultrathin nanosheets (thickness of 3.8 nm) with abundant oxygen vacancies (OVs). During the hydrothermal process, PVP plays a template role in controlling the orientation of the crystallite growth, leading to the forming of nanosheets. Meanwhlie, ethylene glycol would induce the self-assembly of nanosheets into a loose hierarchical architecture duo to its stereo-hindrance effect. NSP achieves a twice higher photocatalytic conversion of benzylamine than BiOCl nanosheets (NST) under visible light. XPS, ESR, NH₃-TPD results manifest that NSP possesses more active sites including OVs and unsaturated Bi atoms than NST, because of avoiding the accumulation of ultrathin nanosheets. In situ FTIR reveals that benzylamine molecules can be chemisorbed and activated on BiOCl interfaces via forming -N^…Bi- species. The OVs can facilitate the forming of superoxide radicals (•O₂^-), achieving the selective photooxidation. Finally, a possible synergetic mechanism based on the interaction of reactants and catalyst interfaces was proposed to illustrate the photocatalytic process at the molecular level.

Bio responsive self-assembly of Au-miRNAs for targeted cancer theranostics

Background

MicroRNA (miRNA) therapeutics are a promising approach to cancer treatment. However, this method faces considerable challenges to achieve tissue-specific, efficient, and safe delivery of miRNAs in vivo.

Methods

Herein, we developed a miRNA delivery system based on the in situ self-assembly of Au-miRNA nanocomplexes (Au-miRNA NCs). Within the cancer microenvironment, we constructed in situ self-assembled Au-miRNA NCs by coincubating gold salt and tumor suppressor mimics, such as let-7a, miRNA-34a, and miRNA-200a.

Findings

The in vitro experiments demonstrated that characteristic in situ self-assembled Au-miRNA NCs were present in cancer cells and can be taken up to inhibit the proliferation of cancer cells effectively. Most importantly, as proven in subcutaneous tumor treatment models, Au-miRNA NCs were especially useful for accurate target imaging and tumor suppression, with significantly enhanced antitumor effects for combination therapy.

Interpretation

These observations highlight that a new strategy for the in situ biosynthesis of Au-let-7a NCs, Au-miR-34a NCs, and Au-miR-200a NCs is feasible, and this may assist in the delivery of more miRNA to tumor cells for cancer treatment. This work opens up new opportunities for the development of miRNA tumor therapy strategies.

Funding

National Natural Science Foundation of China (91753106); Primary Research & Development Plan of Jiangsu Province (BE2019716); National Key Research and Development Program of China (2017YFA0205300).